BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27171493)

  • 1. Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.
    Raghav K; Mhadgut H; McQuade JL; Lei X; Ross A; Matamoros A; Wang H; Overman MJ; Varadhachary GR
    PLoS One; 2016; 11(5):e0154985. PubMed ID: 27171493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcomatoid carcinoma presenting as cancers of unknown primary: a clinicopathological portrait.
    Huey RW; Makawita S; Xiao L; Matamoros A; Estrella JS; Overman MJ; Varadhachary GR; Raghav K
    BMC Cancer; 2019 Oct; 19(1):965. PubMed ID: 31623602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer of Unknown Primary Presenting as Bone-Predominant or Lymph Node-Only Disease: A Clinicopathologic Portrait.
    Huey RW; Smaglo BG; Estrella JS; Matamoros A; Overman MJ; Varadhachary GR; Raghav KPS
    Oncologist; 2021 Apr; 26(4):e650-e657. PubMed ID: 33524217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer of unknown primary: Incidence rates, risk factors and survival among adolescents and young adults.
    Pavlidis N; Rassy E; Smith-Gagen J
    Int J Cancer; 2020 Mar; 146(6):1490-1498. PubMed ID: 31144291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical review of the investigation and management of carcinoma of unknown primary in a single cancer network.
    Shaw PH; Adams R; Jordan C; Crosby TD
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):87-95. PubMed ID: 17305260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.
    Kodaira M; Yonemori K; Shimoi T; Yoshida A; Yoshida M; Kitano A; Shimomura A; Yunokawa M; Shimizu C; Takiguchi Y; Fujiwara Y; Tamura K
    BMC Cancer; 2018 Feb; 18(1):176. PubMed ID: 29433539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
    Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
    BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver metastases from cancer of unknown primary (CUPL): a retrospective analysis of presentation, management and prognosis in 49 patients and systematic review of the literature.
    Lazaridis G; Pentheroudakis G; Fountzilas G; Pavlidis N
    Cancer Treat Rev; 2008 Dec; 34(8):693-700. PubMed ID: 18584969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival outcomes following craniotomy for intracranial metastases from an unknown primary.
    Gough M; Nielsen M; Coulter IC; Holliman D
    Int J Clin Oncol; 2020 Aug; 25(8):1475-1482. PubMed ID: 32358736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of survival of patients with metastases from known versus unknown primaries: survival in metastatic cancer.
    Riihimäki M; Thomsen H; Hemminki A; Sundquist K; Hemminki K
    BMC Cancer; 2013 Jan; 13():36. PubMed ID: 23356713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
    Trivanović D; Petkovic M; Stimac D
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of prognostic factors in 68 patients with cancer of unknown primary site].
    Kou XG; Liang DL; Zhang QQ; Li XR; Zhao YZ; Gu JF; Lu P
    Zhonghua Zhong Liu Za Zhi; 2011 Oct; 33(10):783-6. PubMed ID: 22335913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
    Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
    World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and survival outcomes of a cohort of patients with cancer of unknown primary in Ontario, Canada.
    Kim CS; Hannouf MB; Sarma S; Rodrigues GB; Rogan PK; Mahmud SM; Winquist E; Brackstone M; Zaric GS
    Acta Oncol; 2015 Nov; 54(10):1781-7. PubMed ID: 25825957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of care and survival outcomes for adolescent and young adult patients with testicular seminoma in the United States: A National Cancer Database analysis.
    Stokes W; Amini A; Maroni PD; Kessler ER; Stokes C; Cost CR; Greffe BS; Garrington TP; Liu AK; Cost NG
    J Pediatr Urol; 2017 Aug; 13(4):386.e1-386.e7. PubMed ID: 28153774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia.
    Boys EL; Gao B; Grimison P; Sutherland S; MacKenzie KL; Reddel RR; Liu J
    Cancer Med; 2024 Mar; 13(6):e7052. PubMed ID: 38523552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.
    Seve P; Ray-Coquard I; Trillet-Lenoir V; Sawyer M; Hanson J; Broussolle C; Negrier S; Dumontet C; Mackey JR
    Cancer; 2006 Dec; 107(11):2698-705. PubMed ID: 17063500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of comorbidities, age, and performance status on the prognosis and treatment of patients with metastatic carcinomas of unknown primary site: a population-based study.
    Seve P; Sawyer M; Hanson J; Broussolle C; Dumontet C; Mackey JR
    Cancer; 2006 May; 106(9):2058-66. PubMed ID: 16583433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Site-specific Chemotherapy Based on Predicted Primary Site by Pathological Profile for Carcinoma of Unknown Primary Site.
    Hasegawa H; Ando M; Yatabe Y; Mitani S; Honda K; Masuishi T; Narita Y; Taniguchi H; Kadowaki S; Ura T; Muro K
    Clin Oncol (R Coll Radiol); 2018 Oct; 30(10):667-673. PubMed ID: 30196846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables.
    Ponce Lorenzo J; Segura Huerta A; Díaz Beveridge R; Giménez Ortiz A; Aparisi Aparisi F; Fleitas Kanonnikoff T; Richart Aznar P; de la Cueva Sapiña H; Montalar Salcedo J
    Clin Transl Oncol; 2007 Jul; 9(7):452-8. PubMed ID: 17652059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.